NEW YORK (
CHANGE IN RATINGS
downgraded at Leerink to Market Perform, Leerink Swann said. Company lacks near-term catalysts. $25 price target.
downgraded at JP Morgan from Neutral to Underweight, JP Morgan said. $72 price target. Company is facing lower end-market demand.
downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $40 price target. Company is seeing slower bookings growth.
downgraded at Leerink from Outperform to Market Perform, Leerink Swann said. See limited near-term earnings upside potential.
upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Company is a market leader and should continue to grow in the Permian basin.
upgraded at Compass Point from Sell to Neutral, Compass Point said. Valuation call, based on an $8 price target.
upgraded at BMO to Market Perform, BMO Capital said. $11.25 price target. Company should benefit from higher panel prices.
downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $40 price target.
downgraded at Baird from Outperform to Neutral, Robert Baird said. $37 price target. Sales visibility has become limited.
downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. $14 price target. Estimates also cut, given lower expected annuity growth.
downgraded at BofA/Merrill to Underperform, Bank of America/Merrill Lynch said. $47 price target. More than half of the company's sales come from Europe.
(WMT - Get Report)
upgraded at Deutsche to Hold from Sell, Deutsche Bank said. $68 price target. Fundamentals are improving and investors should gravitate toward the company's defensive position.
STOCK COMMENTS / EPS CHANGES
(ALL - Get Report)
estimates, target raised at BofA/Merrill. Shares of ALL now seen reaching $43, according to Bank of America/Merrill Lynch said. Company is realizing higher margins. Buy rating.
numbers increased at BofA/Merrill. AMG estimates were raised through 2013, Bank of America/Merrill Lynch said. Company is carrying a lot of operating momentum into the second half of the year. Neutral rating and new $127 price target.